Indiva Q&A
Neil. Before we get into this Q&A I just wanted to tell our readers that the Indiva exhibits at the recent conferences and expos was an absolute show stopper!
Readers, you can access Indiva’s website here. Neil, this is not subreddit but rather CannaInvestor and that means the tough questions get asked. So let’s get right to it …
First of all, thank you for your time for brining our readers up to speed on Indivia. You are a licensed producer under Health Canada with a Production and a Sales license for Dry Cannabis. Before we get into your capital structure and other financial matters of interest to our readers, let’s get the horse before the cart. Many of your planned products require an Oils license – to the degree that you can, what is your strategy with respect to Oils (purchase wholesale, inhouse, license application status if applicable) …?
NDVA:
CCIM:
Thank you for reaching out and your interest in INDIVA.
We do indeed have many great US brands/products under license that would fit in the derivative category (i.e. edibles, vape pens, oral sprays etc.) and these products do require cannabis oil in the manufacturing process. Our plan is to build an extraction facility at our London location and this will be complete in Q1 of 2019. In the mean time, while we amend our license and complete our expansion, we are also in discussions with 3rd party oil extraction and processing facilities so we can move quickly in to this market.
Cheers. Readers, click here for INDIVA’s Q3 corporate presentation. Readers, this corporate presentation has current market data and trends and how INDIVA will be right there at the forefront.
Neil, the strategy presented in that document is as aggressive as it is impressive. Is a key to success to be there in day one as legalisation expands into edibles, beverages, and beyond (creams, animal care, etc)?
64